Ticker · CUSIP 62921N105

NGMUSD

NGM BIOPHARMACEUTICALS INC
···Share
Holders (tracked)
10
Combined shares
4,105,664
Combined value
$6.53M
Last close
Quarter
2024Q1
Tracked holders · last 8 quarters
+1 vs previous quarter over the last 8.
10112022Q22024Q1

SEC event timeline

No SEC events recorded for this ticker yet.

Insider activity

No insider transactions in the last 30 days.

Who moved on this name in 2024Q1

Position changes reported for the latest quarter, grouped by direction.
New positions1
Added to1
Trimmed4
Exited0

Institutional ownership over time

Distinct super-investors holding this ticker · combined dollar value, by quarter.
QuarterHoldersCombined value
2020Q2
6
$80.3M
2020Q3
7
$68.9M
2020Q4
4
$135.2M
2021Q1
6
$157.3M
2021Q2
9
$87.1M
2021Q3
10
$102.0M
2021Q4
8
$75.5M
2022Q1
10
$1.56B
2022Q2
11
$85.8M
2022Q3
11
$76.2M
2022Q4
11
$28.3M
2023Q1
12
$24.2M
2023Q2
11
$15.9M
2023Q3
10
$5.9M
2023Q4
9
$5.0M
2024Q1
10
$6.5M

Who owns NGMUSD

10 super-investors · 2024Q1
Tracked stake
4.11M
shares
Combined value
$7M
% of shares outstanding
shares-out unknown
Quarter action mix
New1Added1Trim4Held4
#ManagerSharesValue
1BlackRock3.00M$5M
2Renaissance Technologies611.3K$972K
3Ken Griffin
Citadel Advisors
342.2K$544K
4Izzy Englander
Millennium Mgmt
66.2K$105K
5Two Sigma Investments27.8K$44K
6Paul Tudor Jones
Tudor Investment
25.1K$40K
7AQR Capital Management17.0K$27K
8T. Rowe Price10.9K$18K
9Ken Griffin
Citadel Advisors
800$1K
10Ken Griffin
Citadel Advisors
200$318

Recent moves

20 transactions
Embed this chart
Paste this iframe anywhere to embed the live NGMUSD chart.
<iframe src="https://openstocks.me/embed/stock/NGMUSD" width="100%" height="480" frameborder="0" loading="lazy" title="NGMUSD chart by OpenStocks" style="border:0;border-radius:12px;background:transparent"></iframe>